In a collaborative effort, AACT jointly with ACMT are active participants in the Choosing Wisely campaign. Choosing Wisely promotes conversations between clinicians and patients to allow patients to choose care that is supported by evidence; not duplicative; free from harm and truly necessary. The complete list of this joint effort is available here.
In a collaborative effort, AACT has engaged with multiple professional societies to establish a multidisciplinary workgroup to evaluate the evidence for intravenous lipid emulsion therapy in acutely poisoned patients. Ad hoc consultants were employed in the rigorous evaluation of the literature.
Methodology for AACT evidence based recommendations on the use of intravenous lipid emulsion therapy in poisoning
Systematic review of the effect of intravenous lipid emulsion therapy for non local anesthetics toxicity
Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity
Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration
Review of the effect of intravenous lipid emulsion on laboratory analyses
Update of position papers on gastrointestinal decontamination for acute overdose
Position Statement: Cathartics
Position Statement: Lavage
Position Statement: Ipecac Syrup
Position Statement: Single Dose Activated Charcoal
Position Statement: Multi Dose Activated Charcoal
Position Statement: Whole Bowel Irrigation